ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 139 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $501,000 | +54.6% | 169,369 | -17.0% | 0.05% | +37.8% |
| Q4 2018 | $324,000 | -66.0% | 203,969 | -21.3% | 0.04% | -30.2% |
| Q3 2018 | $954,000 | +38.5% | 259,169 | +6.5% | 0.05% | +55.9% |
| Q2 2018 | $689,000 | +79.9% | 243,369 | +82.9% | 0.03% | +47.8% |
| Q4 2017 | $383,000 | -73.1% | 133,058 | -58.0% | 0.02% | -76.3% |
| Q3 2017 | $1,423,000 | -20.0% | 316,900 | -18.2% | 0.10% | -16.4% |
| Q2 2017 | $1,778,000 | +52.1% | 387,258 | +39.5% | 0.12% | +84.1% |
| Q1 2017 | $1,169,000 | +34.1% | 277,700 | +31.6% | 0.06% | +21.2% |
| Q4 2016 | $872,000 | +160.3% | 211,027 | +410.4% | 0.05% | +188.9% |
| Q3 2016 | $335,000 | +280.7% | 41,348 | +266.0% | 0.02% | +260.0% |
| Q2 2016 | $88,000 | -30.7% | 11,298 | -12.6% | 0.01% | 0.0% |
| Q1 2015 | $127,000 | – | 12,927 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |